오토텔릭바이오㈜

A-SAM Solution

Autotelic Bio – Synergy Action Mechanism Solution

Autotelic Bio's platform technology is to demonstrate drug action mechanism and to find drug candidates that have synergistic effect by drug-drug interaction utilizing A-SAM solution as the information needed for drug development is efficiently categorized, analyzed from big data such as clinical trials, patent, research papers and etc.

New drug(or Hybrid New Drug) development utilizing this technology is a development strategy that finds new synergy effects or drug new use by studying the action mechanism of drugs that have already been released or under the late development(clinical 2 and 3) as the drugs have already been proven safe and effective.

This R&D strategy is also business development strategy reducing dramatically the failure risk raised by safety or effectiveness issue that may happen during the nonclinical, clinical development stages. In other words, it is a business model that maximizes the chances of commercialization success.

01 Efficacy·Side effect
pharmacological synergistic action
02 Combined therapy
pharmacological synergistic action
03 Synergistic action
by drug repositioning

Big Data
A-SAM Algorithm
Data Optimization and classification
New Drug Development
Globalization

A-SAM Core Research

Big data analysis

Study of pharmacological synergistic mechanism Efficacy, Safety, Patient convenience increase·
Alternative choice increase
Target
1. 1
  
  Innovation:
  
  TGF-ß2 targeting Antisense Oligonucleotide (ASO)+Immuno-oncology
  
  New pharmacological mechanism for cancer treatment
  Improve of demerits of existing immuno-oncology drug
2. 2
  
  Creativity:
  
  Hybrid New Drug(Hypertension + Diabetes)
  
  Proved synergistic effect on blood pressure dropping by combined therapy
  Remove side effects of renal insufficiency, skin carcinoma by long term taking of diuretic
3. 3
  
  Challenge:
  
  Other diseases

TECHNOLOGY

A-SAM Solution

A-SAM
Solution